Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesity, and Type 2 Diabetes: Beyond LDL Cholesterol Global Sugar-Sweetened Beverage Sale Barometer Targeting abdominal obesity in diabetology: What can we do about it? Lifestyle modification in the prevention of type 2 diabetes: The experience with the Diabetes Prevention Program and Look AHEAD studies Hypertrophic obesity is associated with type 2 diabetes and impaired adipogenesis Clinical Management of CVD Risk in Abdominal Obesity and Type 2 Diabetes Targeting Blood Pressure Global dimensions of sugary beverages in programmatic and policy solutions. Physical Activity in the Management of Abdominal Obesity Ectopic Fat: An Important Feature of Intra-Abdominal Obesity in Type 2 Diabetes Managing cardiometabolic risk Fatty acid metabolism in humans Metabolic syndrome and adipose tissue Role of the dysregulated endocannabinoid system in determining cardiometabolic risk. Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk: part I The concept of cardiometabolic risk 
